Intravitreal Mesenchymal Stem Cell Transplantation in Advanced Glaucoma.
Intravitreal Autologous Bone Marrow-derived Mesenchymal Stem Cell Transplantation in Patients With Advanced Glaucoma. Phase I: Safety Study.
Sponsor: Conselho Nacional de Desenvolvimento Científico e Tecnológico
Listed as NCT02330978, this PHASE1 trial focuses on Primary Open-angle Glaucoma and Retinal Degeneration and remains completed. Sponsored by Conselho Nacional de Desenvolvimento Científico e Tecnológico, it has been updated 10 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE1
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE1
▶ Show 5 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE1
-
Aug 2019 — Jan 2021 [monthly]
Completed PHASE1
Status: Unknown Status → Completed
-
Aug 2018 — Aug 2019 [monthly]
Unknown Status PHASE1
Status: Recruiting → Unknown Status
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE1
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE1
First recorded
Jan 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- University of Sao Paulo
For direct contact, visit the study record on ClinicalTrials.gov .